RadNet, Inc. (RDNT)
| Market Cap | 5.98B -0.5% |
| Revenue (ttm) | 2.27B +18.9% |
| Net Income | -21.12M |
| EPS | -0.27 |
| Shares Out | 78.70M |
| PE Ratio | n/a |
| Forward PE | 151.58 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,664,323 |
| Open | 77.21 |
| Previous Close | 78.01 |
| Day's Range | 72.49 - 78.13 |
| 52-Week Range | 50.82 - 85.84 |
| Beta | 1.40 |
| Analysts | Strong Buy |
| Price Target | 94.63 (+24.51%) |
| Earnings Date | Nov 9, 2026 |
About RDNT
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 8 analysts, the average rating for RDNT stock is "Strong Buy." The 12-month stock price target is $94.63, which is an increase of 24.51% from the latest price.
News
RadNet raises FY26 net revenue view to $2.385B-$2.435B from $2.37B-$2.42B
Consensus $2.51B. Raises FY26 adjusted EBITDA view to $350M-$363M from $345M-$358M
RadNet reports Q3 adjusted EPS 30c, consensus 22c
Reports Q3 revenue $638.3M, consensus $639.21M. Dr. Howard Berger, President and Chief Executive Officer of RadNet (RDNT), commented, “We delivered record quarterly Revenue and Adjusted EBITDA in the ...
RadNet Reports Third Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA(1) and Revises Upwards 2026 Financial Guidance Ranges
LOS ANGELES, Nov. 08, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective outpatient diagnostic imaging services and a premier global deve...
RadNet, Inc. Announces Date of its Third Quarter 2026 Financial Results Conference Call
LOS ANGELES, Oct. 29, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and opera...
RadNet Transcript: M&A announcement
The acquisition adds ONRAD’s hospital radiology services for $350 million in cash, 5 million shares, and up to $210 million in earn-out consideration. Management expects $60 million-$65 million of first-year adjusted EBITDA and plans to integrate AI and reporting tools throughout 2027.
RadNet Press release: M&A announcement
RadNet issued a press release on October 27, 2026, disclosing material business information to investors.
RadNet Slides: M&A announcement
RadNet has posted slides in relation to its latest quarterly earnings report, which was published on October 27, 2026.
RadNet to acquire Onrad for $350M, 5M shares upfront
RadNet (RDNT) announced that it has entered into a definitive agreement to acquire Onrad. Onrad, through its more than 130 contracted radiologists, is a provider of teleradiology and in-hospital profe...
RadNet, Inc. Announces Agreement to Acquire ONRAD, Inc.
RadNet announces agreement to acquire ONRAD, combining radiology professional services, AI solutions and outpatient imaging into an integrated offering.
New Study Shows DeepHealth AI Could Help Avoid Nearly One in Five Prostate Biopsies
SOMERVILLE, Mass., Oct. 08, 2026 (GLOBE NEWSWIRE) -- DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), today announced ne...
RadNet partners with WIN-NextGen to cultivate future talent in medical imaging
RadNet (RDNT) announced a collaboration with WIN-NextGen, a workforce innovation network dedicated to cultivating talent across the 3S Workforce, to introduce middle school, high school and young adul...
RadNet and WIN-NextGen™ Form a Collaboration to Inspire the Next Generation of Medical Imaging Professionals
New program introduces students and young adults to careers in radiology through mentorship, digital experiences and hands-on learning. OWINGS MILLS, Md.
RadNet Transcript: Morgan Stanley 24th Annual Global Healthcare Conference
Diagnostic imaging remains fragmented, offering significant consolidation opportunities. Stable Medicare reimbursement and strong commercial negotiations support growth, while technology and AI initiatives drive operational efficiency, new revenue streams, and improved capacity. Strategic partnerships and joint ventures with health systems are expanding, further accelerating growth.
RadNet Transcript: 2026 Jefferies Healthcare Services and Technology Conference
Imaging and digital health segments are both experiencing strong growth, with digital health tools driving productivity and enabling new revenue streams. The unified operating system and expanding hospital partnerships position the company for continued margin expansion and market share gains, while disciplined M&A and AI innovation support a positive long-term outlook.
RadNet, Inc. to Present at the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16th, 2026
LOS ANGELES, Sept. 09, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned an...
RadNet to Host Free Prostate Cancer Webinar on September 19, 2026
LOS ANGELES, Sept. 09, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a ne...
RadNet, Inc. to Present at the Jefferies Healthcare Services and Technology Conference on September 15, 2026
LOS ANGELES, Sept. 08, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned an...
RadNet participates in a conference call with KeyBanc
KeyBanc holds a conference call on PEAT Scan Growth Drivers with CFO Stolper on September 11.
RadNet price target raised to $79 from $65 at Barclays
Barclays analyst Andrew Mok raised the firm’s price target on RadNet (RDNT) to $79 from $65 and keeps an Overweight rating on the shares. The firm updated models in the…
RadNet price target raised to $94 from $90 at Truist
Truist raised the firm’s price target on RadNet (RDNT) to $94 from $90 and keeps a Buy rating on the shares. The firm remain bullish on RadNet post Q2 results…
RadNet Earnings Call Transcript: Q2 2026
Record revenue and adjusted EBITDA were driven by strong advanced imaging volumes, Digital Health growth, and recent acquisitions. Guidance for imaging center revenue, adjusted EBITDA, and free cash flow was raised, while Digital Health ARR and profitability continue to scale.
RadNet Earnings release: Q2 2026
RadNet released its Q2 2026 earnings on August 10, 2026, summarizing the period's financial results.
RadNet Quarterly report: Q2 2026
RadNet has published its Q2 2026 quarterly earnings report on August 10, 2026.
RadNet reports Q2 adjusted EPS 29c, consensus 20c
Reports Q2 revenue $622.7M, consensus $609.33M. Dr. Howard Berger, President and Chief Executive Officer of RadNet (RDNT), commented, “The Imaging Center and Digital Health reportable operating segmen...
RadNet Reports Second Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA(1) and Revises Upwards 2026 Financial Guidance Ranges
Total Company Revenue increased 25.0% to a quarterly record of $622.7 million in the second quarter of 2026 from $498.2 million in the second quarter of 2025 Revenue from the Digital Health reportable...